2024 / 01

Next Paper
DOI: 10.47183/mes.2024.010

CLINICAL CASE

Intracoronary use of levocarnitine for coronary artery stent insertion in high-risk patients

Semigolovskii NYu1,2,3, Balluzek MF1,2, Guslev AB1,2, Mazurenko SO1, Kozaev AV2, Semenova IG2, Nikolskaya EM3, Scheglov AN4
About authors

1 Saint Petersburg State University, Saint Petersburg, Russia

2 Saint Petersburg Clinical Hospital of the Russian Academy of Sciences, Saint Petersburg, Russia

3 Clinical Hospital of the Sokolov North-Western District Scientific and Clinical Center of the Federal Medical Biological Agency, Saint Petersburg, Russia

4 Central Clinical Hospital with a Polyclinic of the Administrative Directorate of the President of the Russian Federation, Moscow, Russia

Correspondence should be addressed: Nikita Yu. Semigolovskii
pr. Kultury, 4, Saint Petersburg, 194291, Russia; ur.xednay@iksvologimes

About paper

Funding: the study was performed as part of the State Assignment No. 075-01609-23-04 “Adjuvant Cytoprotection by Intracoronary Levocarnitine Administration during Revascularization in Patients with Acute and Chronic Coronary Syndrome” (FUEM-2023-0018). Research project No. 1022040701249-2-3.2.4. Agreement No. 075-03-2023-695/1 dated 21.04.2023.

Author contribution: Semigolovskii NYu — study concept and design, text development, literature review; Kozaev AN, Nikolskaya EM, Semenova IG — сollection and processing of material; Mazurenko SO — literature review, material analysis, editing; Guslev AB, Scheglov AN — material analysis; Balluzek MF — material analysis, editing.

Received: 2024-01-29 Accepted: 2024-03-17 Published online: 2024-03-25
|
No data available...